Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses
Fulltext:
Test bestand 13042021.pdf
Size:
180.3Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2020Source
Oncoimmunology, 9, 1, (2020), article 1738813ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Tumorimmunology
Journal title
Oncoimmunology
Volume
vol. 9
Issue
iss. 1
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [227436]
- Electronic publications [107268]
- Faculty of Medical Sciences [86157]
- Open Access publications [76396]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.